MediWound (MDWD) Net Income towards Common Stockholders (2016 - 2025)

MediWound has reported Net Income towards Common Stockholders over the past 13 years, most recently at -$2.4 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 64.3% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached -$28.2 million, down 23.79%, while the annual FY2025 figure was -$23.5 million, 21.8% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$2.4 million at MediWound, up from -$6.9 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $940000.0 in Q2 2023 and troughed at -$13.2 million in Q2 2025.
  • A 5-year average of -$4.6 million and a median of -$4.2 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 138300.0% in 2021 and later skyrocketed 121.63% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at -$4.2 million in 2021, then plummeted by 76.47% to -$7.3 million in 2022, then soared by 79.49% to -$1.5 million in 2023, then tumbled by 341.52% to -$6.6 million in 2024, then skyrocketed by 64.3% to -$2.4 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for MDWD at -$2.4 million in Q4 2025, -$6.9 million in Q3 2025, and -$13.2 million in Q2 2025.